Implementation of high‐throughput non‐invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross‐sectional survey of maternity units and expert interviews

BACKGROUND: Previously, routine antenatal anti‐D prophylaxis (RAADP) was administered to all RhD‐negative mothers to reduce the risk of sensitisation in the UK's National Health Service (NHS). If the baby is RhD‐negative, RAADP is not required. In 2016, the UK National Institute for Health and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryczek, Edyta, White, Judith, Carolan‐Rees, Grace
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496714/
https://www.ncbi.nlm.nih.gov/pubmed/32447792
http://dx.doi.org/10.1111/tme.12702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496714/
https://www.ncbi.nlm.nih.gov/pubmed/32447792
http://dx.doi.org/10.1111/tme.12702

Ejemplares similares